The size of the Middle East & Africa Superdisintegrants Market was calculated at USD 28.74 million in 2022. It is further estimated to be growing at a CAGR of 9.57% and worth USD 45.39 million by 2027.
The factors such as the increasing prevalence of cardiovascular diseases and the growing adoption of orally disintegrants tablets are driving the superdisintegrants market in MEA. Also, the rising emergence of new superdisintegrants for the pharmaceutical industry boosts market growth. In addition, the shifting focus of pharmaceutical manufacturing to the emerging countries such as UAE, Saudi Arabia, and South Africa are expanding the MEA regional market growth.
Other factors such as increasing awareness among the people and the growing healthcare expenditure accelerate the demand for the superdisintegrants market. In addition, the technological advancement in the healthcare sector and the increasing adoption of novel excipients support market growth. When solid dosage forms, such as capsules or tablets, are submerged in liquid, superdisintegrants are added to help them disintegrate. Because of this advantage, superdisintegrants are widely used to produce disintegrating oral formulations, increasing market demand for superdisintegrants. In addition, a growing percentage of pediatric patients and the elderly population cannot take solid medications. Therefore, these compounds are utilized in drug-loaded films to improve performance and maintain high drug content homogeneity by increasing viscosity.
On the other hand, the increasing use of orally disintegrating tablets in the pharmaceutical and nutraceutical industries to treat dysphagia and other diseases is projected to contribute to market growth during the forecast period. Further, increasing investments and funding by the government in healthcare infrastructure and research and development activities are expected to provide lucrative growth opportunities for market growth.
However, safety and the quality concerns associated with the superdisintegrants limit the market growth.
This research report on the Middle East and Africa superdisintegrants market has been segmented and sub-segmented into the following categories:
By Product Type:
By Therapeutic Area:
The MEA is anticipated to grow significantly in the super disintegrants market during the forecast period. The regional market growth is driven by the increasing number of Pediatric patients, the rising prevalence of Alzheimer’s and cardiovascular diseases, and the supportive government policies and investments. Further, the presence of key market players and the implementation of various market strategies such as collaborations, mergers, and acquisitions are strengthening the MEA regional market growth.
South Africa is likely to account for a significant market share during the forecast period due to the advancing healthcare sector, growing geriatric population, and high healthcare expenditure.
UAE is a significant country for MEA regional market growth. The advancing healthcare sector, availability of funding for research and development activities, and local collaboration for product development is are fuelling the market growth.
On the other hand, Saudi Arabia is most likely to record a considerable share in the market during the forecast period. The factors such as supportive government initiatives, increasing prevalence of patient population, growing awareness, and Improving healthcare infrastructure contribute to the market growth.
KEY MARKET PLAYERS:
Companies playing a significant role in the MEA Superdisintegrants Market studied in this report are Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com